MS Patient, Ph.D.: Hoping New Biomarkers Make MS More Predictable

Recent research on various biomarkers might improve the accuracy of diagnosis, the accuracy of predicting progression to MS, and correct treatment choice

Patients are told that MS is unpredictable. It is something we learn firsthand, even before we get a clear-cut diagnosis...

People

MS Research Roundup: March 21, 2014

Tests of HIV Drug in Progress for RRMS; Statin Discovery in Progressive MS; Bench-to-Bedside MS Research Talks Online

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Meetings

Demyelination and Remyelination: From Mechanism to Therapy

A meeting sponsored by The New York Academy of Sciences

Demyelination and Remyelination: From Mechanism to Therapy

June 26, 2014

The New York Academy of Sciences

New York, NY

Meetings

Demyelination and Remyelination: From Mechanism to Therapy

26 Jun 2014

New York City

Papers: 14 Mar 2014 - 21 Mar 2014

Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation.

Atacicept Phase 2 Trial Yields Disappointing Results for MS

Atacicept, which targets B cells, increased rather than decreased exacerbations in relapsing MS

Results from a phase 2 trial of the recombinant fusion protein atacicept raise significant questions about...

Clinical Research, Drug Development

Editors' Pick

Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.

Stellmann J-P, Neuhaus A, Lederer C, Daumer M, Heesen C

PLoS One. 2014; 9(3):e92761. Epub 2014 Mar 20. PMID: 24651401. Abstract

Editors' Pick

Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.

Mameli G, Cossu D, Cocco E, Masala S, Frau J, Marrosu M G, Sechi LA

J Neuroimmunol. 2014 Mar 6. Epub 1969 Dec 31. PMID: 24642384. Abstract

Beyond Reasonable Doubt: The vitamin D piece of the MS puzzle

Clothed cows—and cows wearing only bras—are proving critical in understanding how the body acquires and handles vitamin D and unraveling the vitamin’s role in the development of MS

Last summer, MSDF reported a dramatic study demonstrating that vitamin D supplementation could...

Laboratory Research

Editors' Pick

Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis.

Bible E

Nat Rev Neurol. 2014 Apr; 10(4):182. Epub 2014 Mar 18. PMID: 24638130. Abstract

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

MS Patient, Ph.D.: Hoping New Biomarkers Make MS More Predictable

MS Research Roundup: March 21, 2014

Demyelination and Remyelination: From Mechanism to Therapy

Demyelination and Remyelination: From Mechanism to Therapy

Papers: 14 Mar 2014 - 21 Mar 2014

Atacicept Phase 2 Trial Yields Disappointing Results for MS

Beyond Reasonable Doubt: The vitamin D piece of the MS puzzle

Pages

MSDF Footer

Search form

Papers: 14 Mar 2014 - 21 Mar 2014

Pages